Insmed (INSM) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $25.81 --0%
Revenue Growth %: +20.6%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: +20.6%
Financial Fact:
Operating loss: -37.15M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.74), $0.03 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $34.8 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- NASDAQ (NDAQ) Misses Q1 EPS by 2c, Misses on Revenue
- Altria (MO) delivers in-line earnings, revenue in Q1; shares slightly up
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
